JOURNAL OF THORACIC ONCOLOGY, vol 8 Fishbein, MC; Gardner, B; Milne, GL; Koczywas, M; Cristea, M; Dowell, JE; et al.(2013). MODULATION OF THE CYCLOOXYGENASE PATHWAY IS ASSOCIATED WITH EFFICACY IN A RANDOMIZED PHASE II TRIAL OF ERLOTINIB AND CELECOXIB OR PLACEBO IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC). JOURNAL OF THORACIC ONCOLOGY, 8, S1094-S1094. UCLA: Retrieved from: http://www.escholarship.org/uc/item/92j353f1
Cardiovascular pathology, 19(3), 129-135. Elsevier Inc. Thiene, G, Veinot, J P, Angelini, A, Baandrup, U, Basso, C, Bruneval, P, Buja, L M, Butany, J, d'Amati, G, de Gouveia, R H, Fallon, J T, Fishbein, M C, Gallagher, P J, Kholova, I, Leone, O, McManus, B, Rodriguez, E R, Schoen, F J, Sheppard, M N, Stone, J R, van der Wal, A C & Winters, G L 2010, ' AECVP and SCVP 2009 Recommendations for Training in Cardiovascular Pathology ', Cardiovascular Pathology, vol. 19, no. 3, pp. 129-135 . https://doi.org/10.1016/j.carpath.2009.12.001